Homocysteine and myocardial infarction
Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine...
Gespeichert in:
Veröffentlicht in: | Atherosclerosis 1988-06, Vol.71 (2), p.227-233 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 233 |
---|---|
container_issue | 2 |
container_start_page | 227 |
container_title | Atherosclerosis |
container_volume | 71 |
creator | Israelsson, Bo Brattström, Lars E. Hultberg, Björn L. |
description | Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B
12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI. |
doi_str_mv | 10.1016/0021-9150(88)90147-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78338835</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0021915088901475</els_id><sourcerecordid>78338835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</originalsourceid><addsrcrecordid>eNp9kEFLAzEUhIMotVb_gUIPUvSwmreb7CYXQYpaoeBFzyHJvkBkd6PJVui_d9eWHj29w3wzvBlCLoHeAYXyntIcMgmc3ghxKymwKuNHZAqikhkwwY7J9ICckrOUPimlrAIxIZOCUchlMSWLVWiD3aYefYdz3dXzdhusjrXXzdx3Tkfb-9CdkxOnm4QX-zsjH89P78tVtn57eV0-rjNbiLLPTFmAscC55AJKqaljlRGmNFjz0jDHnMlLAWi4syzXhoNBxoWVTFMmORYzstjlfsXwvcHUq9Yni02jOwybpCpRFEIUfADZDrQxpBTRqa_oWx23Cqga51FjdzV2V0Kov3nUaLva529Mi_XBtN9j0K_3uk5WNy7qzvp0wCpgAFIO2MMOw2GLH49RJeuxs1j7iLZXdfD___ELPdB_bw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78338835</pqid></control><display><type>article</type><title>Homocysteine and myocardial infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Israelsson, Bo ; Brattström, Lars E. ; Hultberg, Björn L.</creator><creatorcontrib>Israelsson, Bo ; Brattström, Lars E. ; Hultberg, Björn L.</creatorcontrib><description>Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B
12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/0021-9150(88)90147-5</identifier><identifier>PMID: 3401293</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ireland Ltd</publisher><subject>Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cystathionine beta-Synthase - deficiency ; Folate ; Folic Acid - blood ; Folic Acid - metabolism ; Heterozygote ; Homocysteine ; Homocystine - blood ; Homocystine - metabolism ; Humans ; Male ; Medical sciences ; Methionine ; Middle Aged ; Myocardial infarction ; Myocardial Infarction - blood ; Myocardial Infarction - enzymology ; Myocardial Infarction - etiology ; Retrospective Studies ; Risk Factors ; Vitamin B 12 ; Vitamin B 12 - blood ; Vitamin B 12 - metabolism</subject><ispartof>Atherosclerosis, 1988-06, Vol.71 (2), p.227-233</ispartof><rights>1988</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</citedby><cites>FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0021915088901475$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7141199$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3401293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Israelsson, Bo</creatorcontrib><creatorcontrib>Brattström, Lars E.</creatorcontrib><creatorcontrib>Hultberg, Björn L.</creatorcontrib><title>Homocysteine and myocardial infarction</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B
12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.</description><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cystathionine beta-Synthase - deficiency</subject><subject>Folate</subject><subject>Folic Acid - blood</subject><subject>Folic Acid - metabolism</subject><subject>Heterozygote</subject><subject>Homocysteine</subject><subject>Homocystine - blood</subject><subject>Homocystine - metabolism</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methionine</subject><subject>Middle Aged</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - blood</subject><subject>Myocardial Infarction - enzymology</subject><subject>Myocardial Infarction - etiology</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Vitamin B 12</subject><subject>Vitamin B 12 - blood</subject><subject>Vitamin B 12 - metabolism</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEFLAzEUhIMotVb_gUIPUvSwmreb7CYXQYpaoeBFzyHJvkBkd6PJVui_d9eWHj29w3wzvBlCLoHeAYXyntIcMgmc3ghxKymwKuNHZAqikhkwwY7J9ICckrOUPimlrAIxIZOCUchlMSWLVWiD3aYefYdz3dXzdhusjrXXzdx3Tkfb-9CdkxOnm4QX-zsjH89P78tVtn57eV0-rjNbiLLPTFmAscC55AJKqaljlRGmNFjz0jDHnMlLAWi4syzXhoNBxoWVTFMmORYzstjlfsXwvcHUq9Yni02jOwybpCpRFEIUfADZDrQxpBTRqa_oWx23Cqga51FjdzV2V0Kov3nUaLva529Mi_XBtN9j0K_3uk5WNy7qzvp0wCpgAFIO2MMOw2GLH49RJeuxs1j7iLZXdfD___ELPdB_bw</recordid><startdate>19880601</startdate><enddate>19880601</enddate><creator>Israelsson, Bo</creator><creator>Brattström, Lars E.</creator><creator>Hultberg, Björn L.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19880601</creationdate><title>Homocysteine and myocardial infarction</title><author>Israelsson, Bo ; Brattström, Lars E. ; Hultberg, Björn L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-b631bc155958169a0f47b8b6bed56b4f4fb2681eb5fc42ab51be458c94a0495e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cystathionine beta-Synthase - deficiency</topic><topic>Folate</topic><topic>Folic Acid - blood</topic><topic>Folic Acid - metabolism</topic><topic>Heterozygote</topic><topic>Homocysteine</topic><topic>Homocystine - blood</topic><topic>Homocystine - metabolism</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methionine</topic><topic>Middle Aged</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - blood</topic><topic>Myocardial Infarction - enzymology</topic><topic>Myocardial Infarction - etiology</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Vitamin B 12</topic><topic>Vitamin B 12 - blood</topic><topic>Vitamin B 12 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Israelsson, Bo</creatorcontrib><creatorcontrib>Brattström, Lars E.</creatorcontrib><creatorcontrib>Hultberg, Björn L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Israelsson, Bo</au><au>Brattström, Lars E.</au><au>Hultberg, Björn L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homocysteine and myocardial infarction</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>1988-06-01</date><risdate>1988</risdate><volume>71</volume><issue>2</issue><spage>227</spage><epage>233</epage><pages>227-233</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Five (24%) subjects out of a group of 21 men, 48–58 years old (mean 54), who had suffered their first myocardial infarction (MI) before the age of 55 and with a low risk profile vis-à-vis conventional risk factors in a health screening preceding the MI, had abnormally high total plasma homocysteine values in the fasting state when investigated within 1–7 years (mean 3) after their MI. The patient group was exactly matched with 36 control subjects for sex, age, diastolic blood pressure, smoking, and serum concentrations of cholesterol and triglycerides. Total plasma homocysteine was negatively correlated to both erythrocyte folate and serum vitamin B
12, and vitamin concentrations below the median of the normal distribution were found in the five with high plasma homocysteine content, indicating a possible involvement of reduced remethylation of plasma homocysteine to methionine. After methionine loading, in 3 of the patient group (14%) homocysteine levels exceeded mean + 2 SD for controls, which may indicate heterozygosity for homocystinuria. Results are consistent with the hypothesis that a high plasma homocysteine content may be a risk factor for MI.</abstract><cop>Amsterdam</cop><pub>Elsevier Ireland Ltd</pub><pmid>3401293</pmid><doi>10.1016/0021-9150(88)90147-5</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9150 |
ispartof | Atherosclerosis, 1988-06, Vol.71 (2), p.227-233 |
issn | 0021-9150 1879-1484 |
language | eng |
recordid | cdi_proquest_miscellaneous_78338835 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cystathionine beta-Synthase - deficiency Folate Folic Acid - blood Folic Acid - metabolism Heterozygote Homocysteine Homocystine - blood Homocystine - metabolism Humans Male Medical sciences Methionine Middle Aged Myocardial infarction Myocardial Infarction - blood Myocardial Infarction - enzymology Myocardial Infarction - etiology Retrospective Studies Risk Factors Vitamin B 12 Vitamin B 12 - blood Vitamin B 12 - metabolism |
title | Homocysteine and myocardial infarction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T06%3A10%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homocysteine%20and%20myocardial%20infarction&rft.jtitle=Atherosclerosis&rft.au=Israelsson,%20Bo&rft.date=1988-06-01&rft.volume=71&rft.issue=2&rft.spage=227&rft.epage=233&rft.pages=227-233&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/0021-9150(88)90147-5&rft_dat=%3Cproquest_cross%3E78338835%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78338835&rft_id=info:pmid/3401293&rft_els_id=0021915088901475&rfr_iscdi=true |